Cervical cancer screening study pulled before starting
NCT ID NCT07211204
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 25 times
Summary
This study was designed to compare the standard Pap smear with a new blood test that looks for three proteins to detect abnormal cervical cells. It planned to include adults aged 18-85 in good general health. However, the study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinica Reina Madre Metepec
San Mateo Atenco, State of Mexico, 52105, Mexico
Conditions
Explore the condition pages connected to this study.